These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 38172444)

  • 1. Clinical recommendations for the inpatient management of lower respiratory tract infections in children and adolescents with severe neurological impairment in Germany.
    Mauritz MD; von Both U; Dohna-Schwake C; Gille C; Hasan C; Huebner J; Hufnagel M; Knuf M; Liese JG; Renk H; Rudolph H; Schulze-Sturm U; Simon A; Stehling F; Tenenbaum T; Zernikow B
    Eur J Pediatr; 2024 Mar; 183(3):987-999. PubMed ID: 38172444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chinese expert consensus on the management of lower respiratory tract infections of
    Pulmonary Infection Assembly of Chinese Thoracic Society
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Aug; 45(8):739-752. PubMed ID: 35927044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower Respiratory Tract Infections in Pediatric Patients with Severe Neurological Impairments: Clinical Observations and Perspectives in a Palliative Care Unit.
    Mauritz MD; Hasan C; Schmidt P; Simon A; Knuf M; Zernikow B
    Children (Basel); 2022 Jun; 9(6):. PubMed ID: 35740789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under.
    Onakpoya IJ; Hayward G; Heneghan CJ
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011530. PubMed ID: 26408070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents.
    Matera MG; Rogliani P; Ora J; Cazzola M
    Expert Opin Pharmacother; 2018 Dec; 19(18):2043-2053. PubMed ID: 30359143
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016).
    He X; Xie M; Li S; Ye J; Peng Q; Ma Q; Lu X; Zhong B
    BMC Infect Dis; 2017 Sep; 17(1):614. PubMed ID: 28893195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of community-acquired lower respiratory tract infections in adults.
    Ortqvist A
    Eur Respir J Suppl; 2002 Jul; 36():40s-53s. PubMed ID: 12168747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic Guidelines for Critically Ill Patients in Nigeria.
    Oladele RO; Ettu AO; Medugu N; Habib A; Egbagbe E; Osinaike T; Makanjuola OB; Ogunbosi B; Irowa OO; Ejembi J; Uwaezuoke NS; Adeleke G; Mutiu B; Ogunsola F; Rotimi V
    West Afr J Med; 2023 Sep; 40(9):962-972. PubMed ID: 37768104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on the pharmacotherapeutic management of lower respiratory tract infections.
    Cazzola M; Rogliani P; Aliberti S; Blasi F; Matera MG
    Expert Opin Pharmacother; 2017 Jul; 18(10):973-988. PubMed ID: 28480770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does one choose the appropriate pharmacotherapy for children with lower respiratory tract infections?
    Esposito S; Bianchini S; Argentiero A; Neglia C; Principi N
    Expert Opin Pharmacother; 2020 Oct; 21(14):1739-1747. PubMed ID: 32567405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observational multi-centre, prospective study to characterize novel pathogen-and host-related factors in hospitalized patients with lower respiratory tract infections and/or sepsis - the "TAILORED-Treatment" study.
    van Houten CB; Oved K; Eden E; Cohen A; Engelhard D; Boers S; Kraaij R; Karlsson R; Fernandez D; Gonzalez E; Li Y; Stubbs A; Moore ERB; Hays JP; Bont LJ
    BMC Infect Dis; 2018 Aug; 18(1):377. PubMed ID: 30086729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
    Young M; Plosker GL
    Pharmacoeconomics; 2001; 19(11):1135-75. PubMed ID: 11735679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperacillin/tazobactam vs carbapenems for patients with bacterial infection: Protocol for a systematic review.
    Petersen MW; Perner A; Sjövall F; Jonsson AB; Steensen M; Andersen JS; Achiam MP; Frimodt-Møller N; Møller MH
    Acta Anaesthesiol Scand; 2019 Aug; 63(7):973-978. PubMed ID: 31020663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey.
    Huchon GJ; Gialdroni-Grassi G; Léophonte P; Manresa F; Schaberg T; Woodhead M
    Eur Respir J; 1996 Aug; 9(8):1590-5. PubMed ID: 8866577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antibiotics contrary to guidelines for children's lower respiratory tract infections in different health care settings.
    Poutanen R; Korppi M; Csonka P; Pauniaho SL; Renko M; Palmu S
    Eur J Pediatr; 2023 Oct; 182(10):4369-4377. PubMed ID: 37464182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of mNGS in the Etiological Analysis of Lower Respiratory Tract Infections and the Prediction of Drug Resistance.
    Liu H; Zhang Y; Yang J; Liu Y; Chen J
    Microbiol Spectr; 2022 Feb; 10(1):e0250221. PubMed ID: 35171007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial and viral respiratory tract microbiota and host characteristics in children with lower respiratory tract infections: a matched case-control study.
    Man WH; van Houten MA; Mérelle ME; Vlieger AM; Chu MLJN; Jansen NJG; Sanders EAM; Bogaert D
    Lancet Respir Med; 2019 May; 7(5):417-426. PubMed ID: 30885620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient antibiotic use attributable to viral acute lower respiratory tract infections during the cold season in France, 2010-2017.
    Cheysson F; Brun-Buisson C; Opatowski L; Le Fouler L; Caserio-Schönemann C; Pontais I; Guillemot D; Watier L
    Int J Antimicrob Agents; 2021 Jun; 57(6):106339. PubMed ID: 33852933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a clinical decision rule on antibiotic prescription for children with suspected lower respiratory tract infections presenting to European emergency departments: a simulation study based on routine data.
    Hagedoorn NN; Wagenaar JHL; Nieboer D; Bath D; Von Both U; Carrol ED; Eleftheriou I; Emonts M; Van Der Flier M; De Groot R; Herberg J; Kohlmaier B; Levin M; Lim E; Maconochie I; Martinon-Torres F; Nijman R; Pokorn M; Rivero Calle I; Tsolia M; Yeung S; Zavadska D; Zenz W; Vermont CL; Oostenbrink R; Moll HA;
    J Antimicrob Chemother; 2021 Apr; 76(5):1349-1357. PubMed ID: 33564871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effective treatment of lower respiratory tract infections.
    Garrelts JC; Herrington AM
    Pharmacoeconomics; 1996 Jul; 10(1):36-58. PubMed ID: 10160469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.